KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Deffered Revenue: 2009-2025

Historic Non-Current Deffered Revenue for Novavax (NVAX) over the last 15 years, with Sep 2025 value amounting to $397.1 million.

  • Novavax's Non-Current Deffered Revenue fell 22.95% to $397.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $397.1 million, marking a year-over-year decrease of 22.95%. This contributed to the annual value of $446.8 million for FY2024, which is 28.19% down from last year.
  • As of Q3 2025, Novavax's Non-Current Deffered Revenue stood at $397.1 million, which was down 0.54% from $399.3 million recorded in Q2 2025.
  • Novavax's 5-year Non-Current Deffered Revenue high stood at $1.0 billion for Q3 2022, and its period low was $172.5 million during Q4 2021.
  • In the last 3 years, Novavax's Non-Current Deffered Revenue had a median value of $515.4 million in 2024 and averaged $514.1 million.
  • Per our database at Business Quant, Novavax's Non-Current Deffered Revenue soared by 246.80% in 2023 and then plummeted by 51.33% in 2025.
  • Over the past 5 years, Novavax's Non-Current Deffered Revenue (Quarterly) stood at $172.5 million in 2021, then rose by 4.01% to $179.4 million in 2022, then skyrocketed by 246.80% to $622.2 million in 2023, then fell by 28.19% to $446.8 million in 2024, then declined by 22.95% to $397.1 million in 2025.
  • Its Non-Current Deffered Revenue was $397.1 million in Q3 2025, compared to $399.3 million in Q2 2025 and $409.6 million in Q1 2025.